JPWO2023139147A5 - - Google Patents
Info
- Publication number
- JPWO2023139147A5 JPWO2023139147A5 JP2024543244A JP2024543244A JPWO2023139147A5 JP WO2023139147 A5 JPWO2023139147 A5 JP WO2023139147A5 JP 2024543244 A JP2024543244 A JP 2024543244A JP 2024543244 A JP2024543244 A JP 2024543244A JP WO2023139147 A5 JPWO2023139147 A5 JP WO2023139147A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- gepotidacin
- vancomycin
- infections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263301522P | 2022-01-21 | 2022-01-21 | |
| US63/301,522 | 2022-01-21 | ||
| PCT/EP2023/051177 WO2023139147A1 (en) | 2022-01-21 | 2023-01-19 | Gepotidacin and vancomycin for use in the treatment of an infection caused by staphylococcus saprophyticus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025502442A JP2025502442A (ja) | 2025-01-24 |
| JPWO2023139147A5 true JPWO2023139147A5 (https=) | 2026-01-22 |
| JP2025502442A5 JP2025502442A5 (https=) | 2026-01-22 |
Family
ID=85108785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024543244A Pending JP2025502442A (ja) | 2022-01-21 | 2023-01-19 | Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ｓａｐｒｏｐｈｙｔｉｃｕｓによって引き起こされる感染症の処置における使用のためのゲポチダシンおよびバンコマイシン |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250099535A1 (https=) |
| EP (1) | EP4465989A1 (https=) |
| JP (1) | JP2025502442A (https=) |
| CN (1) | CN118574619A (https=) |
| CA (1) | CA3240991A1 (https=) |
| WO (1) | WO2023139147A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA015821B1 (ru) | 2007-04-20 | 2011-12-30 | Глэксо Груп Лимитед | Трициклические азотсодержащие соединения в качестве антибактериальных агентов |
| WO2020201833A1 (en) * | 2019-04-03 | 2020-10-08 | Glaxomithkline Intellectual Property Development Limited | Gepotidacin for use in the treatment of bacterial urinary tract infections |
-
2023
- 2023-01-19 US US18/728,991 patent/US20250099535A1/en active Pending
- 2023-01-19 JP JP2024543244A patent/JP2025502442A/ja active Pending
- 2023-01-19 EP EP23702056.5A patent/EP4465989A1/en active Pending
- 2023-01-19 WO PCT/EP2023/051177 patent/WO2023139147A1/en not_active Ceased
- 2023-01-19 CA CA3240991A patent/CA3240991A1/en active Pending
- 2023-01-19 CN CN202380017824.7A patent/CN118574619A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022058688A5 (https=) | ||
| AU2018357775B2 (en) | New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD) | |
| JP2018513188A5 (https=) | ||
| JP2012082219A (ja) | 感染症の治療 | |
| CN111939156B (zh) | 一种联合抗菌药物组合物及其应用 | |
| JP2020529995A5 (https=) | ||
| CL2024003601A1 (es) | Nuevas combinaciones terapéuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2018505218A5 (https=) | ||
| JP2021512086A5 (https=) | ||
| JPWO2023139147A5 (https=) | ||
| KR20200013719A (ko) | 레모글리플로진의 경구 약학적 제제 | |
| CN115607545B (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| JPWO2022218958A5 (https=) | ||
| JPWO2022106711A5 (https=) | ||
| JPWO2021004910A5 (https=) | ||
| JP2014037445A (ja) | 抵抗性統合失調症およびその他のｃｎｓ疾患の治療 | |
| JPWO2021070054A5 (https=) | ||
| JPWO2022076818A5 (https=) | ||
| WO2019145926A1 (en) | Stable thiamine containing pharmaceutical formulations | |
| CN115279354B (zh) | 氯胺酮用于治疗恶病质的用途 | |
| JPWO2021178371A5 (https=) | ||
| JP2020527607A5 (https=) | ||
| JPWO2021184115A5 (https=) | ||
| Holly | Optimization of the Acetazolamide Scaffold to Develop Effective Antibiotics against Vancomycin-resistant Enterococci | |
| JPWO2019152627A5 (https=) |